Literature DB >> 29411265

Rare Risk Variants Identification by Identity-by-Descent Mapping and Whole-Exome Sequencing Implicates Neuronal Development Pathways in Schizophrenia and Bipolar Disorder.

C Salvoro1, S Bortoluzzi2, A Coppe2, G Valle1, E Feltrin1, M L Mostacciuolo1, G Vazza3.   

Abstract

Schizophrenia (SCZ) and bipolar disorder (BPD) are highly heritable disorders with an estimated co-heritability of 68%. Hundreds of common alleles have been implicated, but recently a role for rare, high-penetrant variants has been also suggested in both disorders. This study investigated a familial cohort of SCZ and BPD patients from a closed population sample, where the high recurrence of the disorders and the homogenous genetic background indicate a possible enrichment in rare risk alleles. A total of 230 subjects (161 cases, 22 unaffected relatives, and 47 controls) were genetically investigated through an innovative strategy that integrates identity-by-descent (IBD) mapping and whole-exome sequencing (WES). IBD analysis allowed to track high-risk haplotypes (IBDrisk) shared exclusively by multiple patients from different families and possibly carrying the most penetrant alleles. A total of 444 non-synonymous sequence variants, of which 137 disruptive, were identified in IBDrisk haplotypes by WES. Interestingly, gene sets previously implicated in SCZ (i.e., post-synaptic density (PSD) proteins, voltage-gated calcium channels (VGCCs), and fragile X mental retardation protein (FMRP) targets) were found significantly enriched in genes carrying IBDrisk variants. Further, IBDrisk variants were preferentially affecting genes involved in the extracellular matrix (ECM) biology and axon guidance processes which appeared to be functionally connected in the pathway-derived meta-network analysis. Results thus confirm rare risk variants as key factors in SCZ and BPD pathogenesis and highlight a role for the development of neuronal connectivity in the etiology of both disorders.

Entities:  

Keywords:  bipolar disorder; development of neuronal connectivity; identity-by-descent; rare variants; schizophrenia; whole-exome sequencing

Mesh:

Year:  2018        PMID: 29411265     DOI: 10.1007/s12035-018-0922-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  38 in total

1.  Factor V Leiden in Chioggia: a prevalence study in patients with venous thrombosis, their blood relatives and the general population.

Authors:  Gianluca Gessoni; Sara Valverde; Rosa Canistro; Fabio Manoni
Journal:  Blood Transfus       Date:  2010-07       Impact factor: 3.443

2.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

Review 3.  Regulation of axonal outgrowth and pathfinding by integrin-ECM interactions.

Authors:  Jonathan P Myers; Miguel Santiago-Medina; Timothy M Gomez
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

Review 4.  Neural ECM in addiction, schizophrenia, and mood disorder.

Authors:  Bart R Lubbers; August B Smit; Sabine Spijker; Michel C van den Oever
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

5.  A polygenic burden of rare disruptive mutations in schizophrenia.

Authors:  Shaun M Purcell; Jennifer L Moran; Menachem Fromer; Douglas Ruderfer; Nadia Solovieff; Panos Roussos; Colm O'Dushlaine; Kimberly Chambert; Sarah E Bergen; Anna Kähler; Laramie Duncan; Eli Stahl; Giulio Genovese; Esperanza Fernández; Mark O Collins; Noboru H Komiyama; Jyoti S Choudhary; Patrik K E Magnusson; Eric Banks; Khalid Shakir; Kiran Garimella; Tim Fennell; Mark DePristo; Seth G N Grant; Stephen J Haggarty; Stacey Gabriel; Edward M Scolnick; Eric S Lander; Christina M Hultman; Patrick F Sullivan; Steven A McCarroll; Pamela Sklar
Journal:  Nature       Date:  2014-01-22       Impact factor: 49.962

6.  Whole-exome sequencing of individuals from an isolated population implicates rare risk variants in bipolar disorder.

Authors:  F Lescai; T D Als; Q Li; M Nyegaard; G Andorsdottir; M Biskopstø; A Hedemand; A Fiorentino; N O'Brien; A Jarram; J Liang; J Grove; J Pallesen; E Eickhardt; M Mattheisen; L Bolund; D Demontis; A G Wang; A McQuillin; O Mors; J Wang; A D Børglum
Journal:  Transl Psychiatry       Date:  2017-02-14       Impact factor: 6.222

7.  De novo mutations in schizophrenia implicate synaptic networks.

Authors:  Menachem Fromer; Andrew J Pocklington; David H Kavanagh; Hywel J Williams; Sarah Dwyer; Padhraig Gormley; Lyudmila Georgieva; Elliott Rees; Priit Palta; Douglas M Ruderfer; Noa Carrera; Isla Humphreys; Jessica S Johnson; Panos Roussos; Douglas D Barker; Eric Banks; Vihra Milanova; Seth G Grant; Eilis Hannon; Samuel A Rose; Kimberly Chambert; Milind Mahajan; Edward M Scolnick; Jennifer L Moran; George Kirov; Aarno Palotie; Steven A McCarroll; Peter Holmans; Pamela Sklar; Michael J Owen; Shaun M Purcell; Michael C O'Donovan
Journal:  Nature       Date:  2014-01-22       Impact factor: 49.962

8.  Graphite Web: Web tool for gene set analysis exploiting pathway topology.

Authors:  Gabriele Sales; Enrica Calura; Paolo Martini; Chiara Romualdi
Journal:  Nucleic Acids Res       Date:  2013-05-10       Impact factor: 16.971

9.  Lack of collagen VI promotes neurodegeneration by impairing autophagy and inducing apoptosis during aging.

Authors:  Matilde Cescon; Peiwen Chen; Silvia Castagnaro; Ilaria Gregorio; Paolo Bonaldo
Journal:  Aging (Albany NY)       Date:  2016-05       Impact factor: 5.682

10.  Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia.

Authors:  Giulio Genovese; Menachem Fromer; Eli A Stahl; Douglas M Ruderfer; Kimberly Chambert; Mikael Landén; Jennifer L Moran; Shaun M Purcell; Pamela Sklar; Patrick F Sullivan; Christina M Hultman; Steven A McCarroll
Journal:  Nat Neurosci       Date:  2016-10-03       Impact factor: 24.884

View more
  8 in total

1.  Discovery of rare variants implicated in schizophrenia using next-generation sequencing.

Authors:  Raina Rhoades; Fatimah Jackson; Shaolei Teng
Journal:  J Transl Genet Genom       Date:  2019-01-20

2.  MAP2 immunoreactivity deficit is conserved across the cerebral cortex within individuals with schizophrenia.

Authors:  Rebecca DeGiosio; Ryan M Kelly; Adam M DeDionisio; Jason T Newman; Kenneth N Fish; Allan R Sampson; David A Lewis; Robert A Sweet
Journal:  NPJ Schizophr       Date:  2019-08-28

3.  Rare compound heterozygous missense SPATA7 variations and risk of schizophrenia; whole-exome sequencing in a consanguineous family with affected siblings, follow-up sequencing and a case-control study.

Authors:  Hirofumi Igeta; Yuichiro Watanabe; Ryo Morikawa; Masashi Ikeda; Ikuo Otsuka; Satoshi Hoya; Masataka Koizumi; Jun Egawa; Akitoyo Hishimoto; Nakao Iwata; Toshiyuki Someya
Journal:  Neuropsychiatr Dis Treat       Date:  2019-08-19       Impact factor: 2.570

4.  Collagen VI deficiency causes behavioral abnormalities and cortical dopaminergic dysfunction.

Authors:  Ilaria Gregorio; Maddalena Mereu; Gabriella Contarini; Luca Bello; Claudio Semplicini; Francesca Burgio; Loris Russo; Stefania Sut; Stefano Dall'Acqua; Paola Braghetta; Carlo Semenza; Elena Pegoraro; Francesco Papaleo; Paolo Bonaldo; Matilde Cescon
Journal:  Dis Model Mech       Date:  2022-09-21       Impact factor: 5.732

5.  Abnormally Methylated FMR1 in Absence of a Detectable Full Mutation in a U.S.A Patient Cohort Referred for Fragile X Testing.

Authors:  Charles H Hensel; Rena J Vanzo; Megan M Martin; Ling Ling; Solange M Aliaga; Minh Bui; David I Francis; Hope Twede; Michael H Field; Jonathon W Morison; David J Amor; David E Godler
Journal:  Sci Rep       Date:  2019-10-25       Impact factor: 4.379

6.  A linkage and exome study of multiplex families with bipolar disorder implicates rare coding variants of ANK3 and additional rare alleles at 10q11-q21.

Authors:  Claudio Toma; Alex D Shaw; Anna Heath; Kerrie D Pierce; Philip B Mitchell; Peter R Schofield; Janice M Fullerton
Journal:  J Psychiatry Neurosci       Date:  2021-03-17       Impact factor: 6.186

7.  MAP2 is differentially phosphorylated in schizophrenia, altering its function.

Authors:  M J Grubisha; X Sun; M L MacDonald; M Garver; Z Sun; K A Paris; D S Patel; R A DeGiosio; D A Lewis; N A Yates; C Camacho; G E Homanics; Y Ding; R A Sweet
Journal:  Mol Psychiatry       Date:  2021-02-01       Impact factor: 15.992

Review 8.  Genomic and neuroimaging approaches to bipolar disorder.

Authors:  Mojtaba Oraki Kohshour; Sergi Papiol; Christopher R K Ching; Thomas G Schulze
Journal:  BJPsych Open       Date:  2022-02-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.